13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)

Page 4 of 14

Page 4 of 14 – SEC Filing

CUSIP No. 185575107
1
NAME OF REPORTING PERSON

Samuel D. Isaly
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b)
3
SEC USE ONLY
4
SOURCE OF FUNDS

N/A
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION

United States
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
SOLE VOTING POWER

0
8
SHARED VOTING POWER

10,425,225
9
SOLE DISPOSITIVE POWER

0
10
SHARED DISPOSITIVE POWER

10,425,225
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

10,425,225
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  (See Instructions)
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

34.15%*
14
TYPE OF REPORTING PERSON (See Instructions)

IN

* This percentage is calculated based upon 30,526,584 Common Shares (as defined below) of the Issuer outstanding, as set forth in the Issuer’s Final Prospectus filed with the Securities and Exchange Commission on August 2, 2017 pursuant to Rule 424(b)(4) of the Securities Act of 1933, as amended.

Follow Clementia Pharmaceuticals Inc.

Page 4 of 14